<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02425761</url>
  </required_header>
  <id_info>
    <org_study_id>CER-1403-13857</org_study_id>
    <nct_id>NCT02425761</nct_id>
  </id_info>
  <brief_title>The CSF Shunt Entry Site Trial</brief_title>
  <official_title>A Randomized Controlled Trial of Anterior Versus Posterior Entry Site for Cerebrospinal Fluid Shunt Insertion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hydrocephalus Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Calgary</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Southern California</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Baylor College of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare the survival time (time to first shunt failure) of
      ventriculoperitoneal (VP) shunts inserted through an anterior entry site with those inserted
      through a posterior entry site in children. Shunt entry site is the location on the head that
      the shunt catheter enters the brain on its path to the fluid-filled spaces in the brain, the
      ventricles. Entry sites can be anterior or posterior.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a multi-centered, randomized, controlled trial comparing two commonly used CSF
      shunt insertion techniques, anterior and posterior entry site. There is conflicting
      information and opinions in the pediatric hydrocephalus literature regarding entry site's
      effect on shunt survival. This trial is designed to detect a 10% or more difference in the
      rate of shunt survival at one year between the two techniques.

      The trial will be conducted by the Hydrocephalus Clinical Research Network and the
      Hydrocephalus Association. It is a four year study with an estimated sample size of 448
      patients. Patients will be randomized in the operating room. Subjects will be followed for a
      minimum of 18 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Shunt Failure determined by clinical and radiographic findings</measure>
    <time_frame>Within 18 months to 44 months from shunt insertion surgery</time_frame>
    <description>Shunt failure occurs when the shunt is obstructed, infected, over-drains, or does not drain the entire ventricular system. Shunt failure will be confirmed by radiographic and/ or operative findings, and all failures will be reviewed by a blinded adjudication committee. Subjects will be monitored for shunt failure at each scheduled and unscheduled clinical visit throughout the study. Survival analysis will be used to compare time to shunt failure in each treatment group. The last subject entered into the trial will be followed for 18 months and accrual is expected to take 26 months (maximum follow up 44 months).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient quality of life measured by the Pediatric Quality of Life Inventory (PedsQL)</measure>
    <time_frame>1 week and 1 year after shunt surgery</time_frame>
    <description>A validated quality of life measure will be administered to all subjects/ caretakers at enrollment and at the above time intervals.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of surgery (minutes)</measure>
    <time_frame>Shunt insertion surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Location of ventricular catheter tip on brain imaging</measure>
    <time_frame>within 1 year of shunt surgery</time_frame>
    <description>Position of the ventricular catheter on the first postoperative imaging study will be assessed on postoperative imaging studies obtained within 1 year of shunt insertion surgery. The frequency of catheter tips in poor locations (e.g. within brain parenchyma) will be compared between treatment groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and type of shunt revisions</measure>
    <time_frame>Within 18 months to 44 months from shunt insertion surgery</time_frame>
    <description>The number of shunt revisions required by each subject from the time of shunt insertion to the conclusion of the study will be compared. All subjects will be followed for at least 18 months.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">448</enrollment>
  <condition>Hydrocephalus</condition>
  <arm_group>
    <arm_group_label>Anterior Entry SIte</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Anterior entry site is defined as shunt surgery with catheter entry into the brain from an opening near the coronal suture, on the top of the head and near the front. Specifically, anterior entry is defined as ventricular catheter entry less than 1 centimeter anterior to the coronal suture near the mid-pupillary line.
Subjects randomized to this arm will undergo ventriculoperitoneal shunt insertion surgery using an anterior entry site.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Posterior Entry Site</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Posterior entry site is defined as shunt surgery with catheter entry into the brain from an opening near the lambdoid suture, on the back of the head. Specifically, posterior entry is defined as ventricular catheter entry 4 to 7 centimeters above the external occipital protuberance (inion), near the mid-pupillary line.
Subjects randomized to this arm will undergo ventriculoperitoneal shunt insertion surgery using a posterior entry site.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ventriculoperitoneal shunt insertion surgery</intervention_name>
    <description>The most common treatment for hydrocephalus is the placement of a ventriculoperitoneal shunt in the operating room. A shunt is a flexible tube placed into the ventricular system, fluid filled chambers, of the brain that diverts the flow of CSF into another region of the body, usually the abdomen, also known as the peritoneal cavity, where it can be absorbed.</description>
    <arm_group_label>Anterior Entry SIte</arm_group_label>
    <arm_group_label>Posterior Entry Site</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Less than 18 years of age at the time of shunt insertion; AND

          2. Clinical evidence of hydrocephalus that requires a simple ventriculoperitoneal shunt
             as determined by a pediatric neurosurgeon; AND

          3. No prior history of shunt insertion (a history of an external ventricular drain,
             ventricular reservoir, subgaleal shunt, and or endoscopic third ventriculostomy with
             or without choroid plexus coagulation is permissible); AND

          4. Ventriculomegaly on imaging.

        Exclusion Criteria:

          1. Need of a shunt that is not a simple ventriculoperitoneal shunt. For example: Patients
             who require more than one intracranial catheter are excluded. Patients who require a
             ventricular shunt that terminates in the atrium of the heart, the pleural cavity, the
             gallbladder, or any other terminal location that is not the peritoneal cavity are
             excluded. Patients who require a subdural to peritoneal or a cyst to peritoneal shunt
             are excluded.

          2. Active CSF or abdominal infection;

          3. CSF leak without hydrocephalus;

          4. Pseudotumor cerebri;

          5. Hydranencephaly;

          6. Loculations within the ventricular system (e.g. large intraventricular cysts or
             ventricular adhesions which create compartments that distort the ventricular anatomy;
             isolated trapped lateral ventricle). A small cyst within the ventricle does not meet
             these criteria;

          7. Other difficulties that would preclude follow up at one year (e.g. terminal illness
             with life expectancy less than 18 months; family plans to move out of region or
             country);

          8. A bilateral scalp, bone, or ventricular lesion that makes placement of either an
             anterior or a posterior shunt impracticable (e.g. cutis aplasia);

          9. Bilateral slit like frontal horns or trigones defined as the widest distance between
             the medial and lateral walls less than 3 millimeters.

         10. Patient is scheduled to have an intra-ventricular procedure (e.g. ETV, endoscopic
             biopsy, arachnoid cyst fenestration, fenestration of septum pellucidum) in addition to
             possible or definite VP shunt.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William E Whitehead, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Kestle, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Utah</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vanessa Wall</last_name>
    <phone>(801) 662-5343</phone>
    <email>vanessa.l.wall@hsc.utah.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marcie Langley</last_name>
    <phone>(801) 662-5364</phone>
    <email>marcie.langley@hsc.utah.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anastasia Arynchyna, MPH</last_name>
      <phone>205-638-9653</phone>
      <email>arynch@uab.edu</email>
    </contact>
    <contact_backup>
      <last_name>Curtis Rozzelle, MD</last_name>
      <phone>205-638-9653</phone>
      <email>Curtis.Rozzelle@childrensal.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Krieger, MD</last_name>
      <email>MKrieger@chla.usc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Christina Artime</last_name>
      <email>cartime@chla.usc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Todd Hankinson, MD</last_name>
      <email>Todd.Hankinson@childrenscolorado.org</email>
    </contact>
    <contact_backup>
      <last_name>Susan Staulcup</last_name>
      <email>SUSAN.STAULCUP@UCDENVER.EDU</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Children's Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam Loudermilk</last_name>
      <email>alouder1@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>Edward Ahn, MD</last_name>
      <email>eahn4@jhmi.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St. Louis Children's Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diego Morales</last_name>
      <phone>314-454-2810</phone>
      <email>moralesd@wudosis.wustl.edu</email>
    </contact>
    <contact_backup>
      <last_name>David Limbrick, MD</last_name>
      <phone>314-454-2810</phone>
      <email>limbrickd@wudosis.wustl.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Pindrik, MD</last_name>
      <email>Jonathan.Pindrik@nationwidechildrens.org</email>
    </contact>
    <contact_backup>
      <last_name>Adrienne Boczar</last_name>
      <email>Adrienne.Boczar@nationwidechildrens.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Diamond</last_name>
      <phone>412-692-9965</phone>
      <email>harlankl@UPMC.EDU</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Monroe Carell Jr Children's Hospital at Vanderbilt</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen R Gannon</last_name>
      <phone>615-936-6809</phone>
      <email>stephen.r.gannon@vanderbilt.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Children's Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheila Martinez</last_name>
      <phone>832-822-3950</phone>
      <email>srmarti2@texaschildrens.org</email>
    </contact>
    <contact_backup>
      <last_name>William E Whitehead, MD</last_name>
      <phone>832-822-3950</phone>
      <email>wewhiteh@texaschildrens.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Primary Children's Medical Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84113</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason Clawson, BA, CCRC</last_name>
      <phone>801-662-5369</phone>
      <email>jason.clawson@hsc.utah.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gloria Bowen, RN</last_name>
      <phone>206-987-5916</phone>
      <email>gloria.bowen@seattlechildrens.org</email>
    </contact>
    <contact_backup>
      <last_name>Amy Anderson, RN</last_name>
      <email>amya9@uw.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Alberta Children's Hospital</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T3B 6A8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jay Riva-Cambrin, MD</last_name>
      <email>Jay.Riva-Cambrin@hsc.utah.edu</email>
    </contact>
    <contact_backup>
      <last_name>Salim Ahmed</last_name>
      <email>salahmed@ucalgary.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>BC Children's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6H 3V4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Cheong</last_name>
      <phone>604-875-2345</phone>
      <phone_ext>7132</phone_ext>
      <email>alexander.cheong@cw.bc.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Homa Ashrafpour</last_name>
      <email>homa.ashrafpour@sickkids.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.hcrn.org</url>
    <description>Hydrocephalus Clinical Research Network Website</description>
  </link>
  <link>
    <url>http://www.hydroassoc.org/</url>
    <description>Hydrocephalus Association Website</description>
  </link>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2015</study_first_submitted>
  <study_first_submitted_qc>April 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 24, 2015</study_first_posted>
  <last_update_submitted>December 20, 2017</last_update_submitted>
  <last_update_submitted_qc>December 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baylor College of Medicine</investigator_affiliation>
    <investigator_full_name>William Whitehead</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Cerebrospinal Fluid Shunts</keyword>
  <keyword>Randomized Controlled Trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocephalus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

